US Stock MarketDetailed Quotes

ATHA Athira

Watchlist
  • 2.480
  • -0.080-3.13%
Trading May 29 13:40 ET
95.05MMarket Cap-813P/E (TTM)

About Athira Company

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Company Profile

SymbolATHA
Company NameAthira
Listing DateSep 18, 2020
Issue Price17.00
Founded2011
CEODr. Mark J. Litton, PhD
MarketNASDAQ
Employees67
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address18706 North Creek Parkway,Suite 104
CityBothell
ProvinceWashington
CountryUnited States of America
Zip Code98011
Phone1-425-620-8501
Websitehttp://www.athira.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Mark J. Litton, PhD
  • Director, President and Chief Executive Officer
  • 2.26M
  • Rachel Lenington
  • Chief Operating Officer and Chief Development Officer
  • --
  • Andrew Gengos
  • Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
  • 1.33M
  • Dr. Kevin Church, PhD
  • Chief Scientific Officer
  • --
  • Grant E. Pickering
  • Independent Director
  • 96.53K
  • James A. Johnson
  • Independent Director
  • 106.87K
  • Barbara Kosacz, J.D.
  • Independent Director
  • 102.39K
  • Joseph Edelman
  • Independent Director
  • 92.77K
  • John M. Fluke, Jr
  • Independent Director
  • 95.89K
  • Dr. Michael A. Panzara, M.D.
  • Independent Director
  • 89.36K
  • Mark Worthington
  • General Counsel and Corporate Secretary
  • --
  • Kelly A. Romano
  • Chairwoman of the Board
  • 124.68K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg